Dr. Bhavna Rani | Biochemistry | Best Researcher Award

Published on by World Top Scientists

Dr. Bhavna Rani | Biochemistry | Best Researcher Award

Researcher at Uppsala university, Sweden

Dr. Bhavna Rani is an accomplished molecular and cell biologist with over a decade of research experience spanning academia and industry across Europe. Her work focuses on cancer biology, stem cells, and cell signaling, employing advanced techniques such as 10X CITE-seq, click chemistry, and high-resolution imaging. She has held postdoctoral positions at prestigious institutions including Uppsala University and the Karolinska Institute, contributing to high-impact research and authoring numerous peer-reviewed publications. Dr. Rani is also actively involved in teaching and mentoring at both master’s and doctoral levels and has received research grants and recognition for her scientific contributions. Her multidisciplinary expertise includes project management, business innovation, and sustainability practices gained through academic-industry collaborations. Fluent in English and proficient in Swedish, she demonstrates strong communication and leadership skills through her roles in scientific committees and postdoctoral associations. Driven by innovation and collaboration, Dr. Rani is committed to advancing biomedical research and its translational applications.

Professional Profile 

ORCID Profile

Education

Dr. Bhavna Rani holds a Marie Curie-funded Ph.D. in Surgical and Experimental Sciences and Cellular Therapies from the University of Bari, Italy, where she conducted translational cancer research focusing on TGF-beta inhibitors in hepatocellular carcinoma. Prior to that, she completed a top-tier Master’s program (M.Sc.) in Oncology from Vrije University, Amsterdam, Netherlands, gaining a solid foundation in cancer biology and experimental therapeutics. She also holds additional certifications in Intellectual Property Law, Research Ethics, Leadership, Sustainability, and Health Policy from prestigious institutions like Uppsala University and Karolinska Institute. These certifications reflect her commitment to continuous learning and her interdisciplinary approach to research. Her diverse educational background across multiple countries has provided her with strong analytical, theoretical, and ethical frameworks, making her well-equipped for advanced scientific research and academic leadership. This comprehensive education forms the backbone of her successful career in molecular biology and translational research.

Professional Experience

Dr. Bhavna Rani has amassed extensive research experience across leading European institutions. She is currently a researcher at Uppsala University, where she works on centrosome clustering and cancer therapeutics. Previously, she was a postdoctoral researcher at the Karolinska Institute, focusing on integrin signaling in stem cells using 10X CITE-seq and advanced 3D culture models. Her career includes multiple postdoctoral roles in Sweden, Italy, Germany, and Spain, covering areas such as MEK therapy resistance in pancreatic cancer and tumor microenvironment imaging using MRI techniques. She has also gained biotech industry experience during her internship at Key2Brain AB, contributing to Alzheimer’s disease models and sustainability protocols. Additionally, she has been involved in scientific advisory roles, market analysis, and mentoring master’s students. Her professional journey highlights her interdisciplinary expertise, international collaborations, and ability to navigate both academic and industrial research environments effectively.

Research Interest

Dr. Bhavna Rani’s research interests lie at the intersection of molecular cell biology, cancer therapeutics, and regenerative medicine. She is particularly focused on understanding the mechanisms of cytokinesis, centrosome clustering, and cell adhesion in both normal and cancerous cells. Her work extends into integrin-mediated signaling, stem cell biology, and the tumor microenvironment, utilizing tools such as 10X CITE-seq, click chemistry, and 3D scaffolds. She is passionate about translating basic cellular mechanisms into therapeutic strategies, especially in targeting cancer stemness, drug resistance, and abnormal cell division. Her interest in translational science is also evident in her past research on liver regeneration and MEK resistance pathways, as well as her involvement in preclinical studies on Alzheimer’s disease. Through a combination of molecular techniques, imaging, and biomaterial sciences, Dr. Rani aims to develop targeted interventions that improve disease outcomes and patient care in oncology and regenerative medicine.

Award and Honor

Dr. Bhavna Rani has received notable recognition throughout her academic and research career. She was a prestigious Marie Curie Fellow during her Ph.D., an award reserved for top-tier researchers in the EU. Her research has been funded by competitive grants such as the A&M Rudberg and Marcus and Amalia Wallenberg Foundation, acknowledging the impact and promise of her scientific contributions. She has served as a reviewer for peer-reviewed journals like Cancer Medicine, further establishing her authority in the biomedical field. Additionally, she has been an active member of scientific societies, including the European Association for the Study of the Liver (EASL) and the European Society for Clinical Investigation (ESCI). She also held leadership roles in postdoctoral associations at Uppsala University and Karolinska Institute. While her list of named awards could expand, her consistent record of grants, fellowships, and leadership roles reflect strong academic recognition.

Conclusion

Dr. Bhavna Rani is a highly accomplished and driven biomedical researcher whose career spans cutting-edge research in cancer biology, stem cells, and regenerative medicine. With a strong academic foundation and wide-ranging professional experience in both academia and industry, she demonstrates a rare blend of scientific excellence, teaching expertise, and interdisciplinary collaboration. Her research has real-world impact, particularly in understanding complex cellular processes like cytokinesis and integrin signaling in disease contexts. She has contributed to multiple peer-reviewed publications and secured competitive funding, affirming the value of her work. Beyond the lab, she actively participates in teaching, mentoring, and scientific communities, showcasing leadership and commitment to the broader research ecosystem. With her deep expertise, innovative thinking, and collaborative mindset, Dr. Rani is exceptionally well-positioned to continue making meaningful contributions to science and society. Her profile makes her a strong candidate for research awards and future leadership roles in biomedical research.

Publications Top Notes

  • Cytokinesis in Suspension: A Distinctive Trait of Mesenchymal Stem Cells

    • Authors: Rani B, Qian H, Johansson S

    • Year: 2025

  • Contribution of Integrin Adhesion to Cytokinetic Abscission and Genomic Integrity

    • Authors: Rani B, Gupta DK, Johansson S, Kamranvar SA

    • Year: 2022

  • Cell Cycle Regulation by Integrin‑Mediated Adhesion

    • Authors: Kamranvar SA, Rani B, Johansson S

    • Year: 2022

  • Platelets as Key Factors in Hepatocellular Carcinoma

    • Authors: Pavlovic N, Rani B, Gerwins P, Heindryckx F

    • Year: 2019

  • Galunisertib Suppresses the Staminal Phenotype in Hepatocellular Carcinoma by Modulating CD44 Expression

    • Authors: Rani B, Malfettone A, Dituri F, et al.

    • Year: 2018

  • Transforming Growth Factor‑β‑Induced Plasticity Causes a Migratory Stemness Phenotype in Hepatocellular Carcinoma

    • Authors: Malfettone A, Soukupova J, Rani B, et al.

    • Year: 2017

  • MicroRNA‑199a‑5p Inhibition Enhances the Liver Repopulation Ability of Human Embryonic Stem Cell‑Derived Hepatic Cells

    • Authors: Möbus S, Yang D, Yuan Q, Lüdtke TH, Rani B, et al.

    • Year: 2014

  • Moving Towards Personalised Therapy in Patients with Hepatocellular Carcinoma: The Role of the Microenvironment

    • Authors: Giannelli G, Rani B, Dituri F, Cao Y, Palasciano G

    • Year: 2014

  • Role of the Tissue Microenvironment as a Therapeutic Target in Hepatocellular Carcinoma

    • Authors: Rani B, Cao Y, Malfettone A, Tomuleasa C, et al.

    • Year: 2014

  • MicroRNA‑221 Overexpression Accelerates Hepatocyte Proliferation During Liver Regeneration

    • Authors: Yuan Q, Loya K, Rani B, Möbus S, et al.

    • Year: 2013

Yunlong Liu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by World Top Scientists

Dr. Yunlong Liu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

lecturer at Tiangong university, China

Dr. Yunlong Liu is a distinguished structural biologist specializing in transcriptional regulation and nuclear receptor mechanisms. He is currently a Lecturer at Tiangong University, where he contributes to cutting-edge research in biochemistry and molecular biology. His expertise lies in protein structure determination, molecular interactions, and drug discovery, particularly in identifying potent inhibitors for nuclear receptors. With multiple high-impact publications, including Nucleic Acids Research and Cell Discovery, Dr. Liu has established himself as a promising researcher in his field. He has secured national-level research funding and actively contributes to prestigious scientific projects. Recognized for his academic excellence, he has received numerous awards, including the Outstanding Doctoral Dissertation Award and National Ph.D. Scholarship. His work not only advances fundamental biological understanding but also holds potential for therapeutic applications. With a strong foundation in research and teaching, Dr. Liu continues to make significant contributions to the field of structural biology.

Professional Profile

Education

Dr. Yunlong Liu completed his Ph.D. in Biochemistry and Molecular Biology at China Agricultural University in 2023, where he conducted groundbreaking research on structural biology and transcriptional regulation. His doctoral work involved the determination of multiple protein and nucleic acid complex structures, providing critical insights into nuclear receptor function. During his Ph.D., he was recognized for his exceptional academic performance, receiving the Outstanding Doctoral Dissertation Award and National Ph.D. Scholarship. Prior to his doctoral studies, he earned his undergraduate degree from a prestigious institution, excelling in both coursework and research. His academic journey has been marked by a strong emphasis on molecular mechanisms and protein interactions, laying the foundation for his current research. With a solid background in structural biology and biochemistry, Dr. Liu has developed expertise in crystallography, molecular modeling, and drug discovery, positioning him as a leading researcher in his field.

Professional Experience

Dr. Yunlong Liu is currently a Lecturer in the College of Life Sciences at Tiangong University, where he teaches and mentors students in biochemistry and molecular biology. Before this role, he conducted extensive doctoral research at China Agricultural University, focusing on protein structural analysis and transcriptional regulation. His research contributions include the identification of a highly potent nuclear receptor inhibitor and the resolution of multiple protein-DNA complex structures. As a key member of several national research projects, he has played an instrumental role in advancing molecular biology research in China. He has also secured independent research funding, serving as the Principal Investigator for a National Natural Science Foundation of China project. His professional experience extends beyond academia, as his research findings have implications for pharmaceutical development and biomedical sciences. Through his teaching and research, Dr. Liu continues to shape the next generation of scientists while making significant contributions to his field.

Research Interests

Dr. Yunlong Liu’s research focuses on the molecular mechanisms of transcriptional regulation, nuclear receptor functions, and protein-nucleic acid interactions. His work in structural biology involves determining the 3D structures of key biomolecules using advanced crystallography techniques, providing crucial insights into gene regulation and disease pathways. He is particularly interested in studying nuclear receptors and their role in gene expression, with the aim of identifying novel therapeutic targets for metabolic and genetic disorders. His research has led to the discovery of a nuclear receptor inhibitor with significantly enhanced efficacy, highlighting the potential for drug development. Additionally, he explores epigenetic modifications and their structural basis, contributing to the broader understanding of gene regulation. With a strong commitment to advancing biomedical research, Dr. Liu continues to explore new methodologies and collaborative approaches to address fundamental questions in biochemistry and molecular biology.

Awards and Honors

Dr. Yunlong Liu has been widely recognized for his outstanding contributions to structural biology and molecular research. He received the Outstanding Doctoral Dissertation Award from China Agricultural University, an honor granted to only one recipient in his college. His academic excellence also earned him the National Ph.D. Scholarship, where he ranked second in his college. Throughout his career, he has been involved in prestigious research projects funded by national and provincial organizations, including the National Natural Science Foundation of China and the Tianjin Top Scientist Studio Program. His achievements in protein structure determination and transcriptional regulation have led to publications in top-tier journals such as Nucleic Acids Research and Cell Discovery. His early accomplishments include awards in mathematical modeling competitions and national scholarships during his undergraduate studies. With a track record of excellence, Dr. Liu continues to receive accolades for his impactful research and academic contributions.

Conclusion

Dr. Yunlong Liu is a strong candidate for the Best Researcher Award, given his high-impact research, prestigious awards, and leadership in structural biology. His work in transcriptional regulation and nuclear receptors is scientifically significant and widely recognized. Strengthening international collaborations, expanding independent funding, and showcasing mentorship contributions could further elevate his standing.

Publications Top Noted

1. Nucleic Acid-Based Therapies

  • Title: The Progress and Evolving Trends in Nucleic-Acid-Based Therapies
  • Authors: Liu, Y., Wang, C., Fu, X., & Ren, M.
  • Year: 2025
  • Journal: Biomolecules
  • DOI: 10.3390/biom15030376

2. Nucleic Acid Recognition and 6mA Demethylation

  • Title: Structural Basis of Nucleic Acid Recognition and 6mA Demethylation by Caenorhabditis elegans NMAD-1A
  • Authors: Shang, G., Yang, M., Li, M., Ma, L., Liu, Y., Ma, J., Chen, Y., Wang, X., Fan, S., Xie, M., et al.
  • Year: 2024
  • Journal: International Journal of Molecular Sciences
  • DOI: 10.3390/ijms25020686

3. Transcriptional Regulation and Structural Insights

  • Title: Structures of Human TR4LBD–JAZF1 and TR4DBD–DNA Complexes Reveal the Molecular Basis of Transcriptional Regulation
  • Authors: Liu, Y., Ma, L., Li, M., Tian, Z., Yang, M., Wu, X., Wang, X., Shang, G., Xie, M., Chen, Y., et al.
  • Year: 2023
  • Journal: Nucleic Acids Research
  • DOI: 10.1093/nar/gkac1259

4. Molecular Recognition of Nucleosomes

  • Title: Structures of MPND Reveal the Molecular Recognition of Nucleosomes
  • Authors: Yang, M., Li, X., Tian, Z., Ma, L., Ma, J., Liu, Y., Shang, G., Liang, A., Wu, W., Chen, Z.
  • Year: 2023
  • Journal: International Journal of Molecular Sciences
  • DOI: 10.3390/ijms24043368

5. Epigenetic Functions and Nucleic Acid Repair

  • Title: Structural Insights into the Interactions and Epigenetic Functions of Human Nucleic Acid Repair Protein ALKBH6
  • Authors: Ma, L., Lu, H., Tian, Z., Yang, M., Ma, J., Shang, G., Liu, Y., Xie, M., Wang, G., Wu, W., et al.
  • Year: 2022
  • Journal: Journal of Biological Chemistry
  • DOI: 10.1016/j.jbc.2022.101671

6. Protein-DNA Complex and Recognition Mechanisms

  • Title: Crystal Structures of REF6 and Its Complex with DNA Reveal Diverse Recognition Mechanisms
  • Authors: Tian, Z., Li, X., Li, M., Wu, W., Zhang, M., Tang, C., Li, Z., Liu, Y., Chen, Z., Yang, M., et al.
  • Year: 2020
  • Journal: Cell Discovery
  • DOI: 10.1038/s41421-020-0150-6

 

Nicolas Carels | Biochemistry | Best Researcher Award

Published on by World Top Scientists

Dr. Nicolas Carels | Biochemistry | Best Researcher Award

Scientist, Fondation Oswaldo Cruz, Brazil

Nicolas Carels is a distinguished Specialist in Science and Technology, focused on Production and Innovation in Public Health at the Fundação Oswaldo Cruz in Brazil. With a robust background in bioinformatics and genomics, he leads cutting-edge research initiatives aimed at advancing public health solutions. 🌍💻

Publication Profile

ORCID

Strengths for the Award

  1. Extensive Experience: Nicolas has over 15 years of research experience in bioinformatics and genomics, including leadership roles at Fundação Oswaldo Cruz, which enhances his credibility and influence in the field.
  2. Diverse Research Contributions: His work spans multiple areas, including public health, sustainable development, and molecular genetics, showcasing a broad application of his expertise. His recent publications on cancer research demonstrate his engagement with pressing global health challenges.
  3. Strong Educational Background: Holding multiple PhDs in biotechnology and phytopathology, along with a master’s degree in management, he combines scientific rigor with practical management skills.
  4. Multilingual Communication: Proficient in several languages (French, English, Italian, Portuguese, and Spanish), Nicolas can communicate effectively in diverse settings, facilitating international collaboration.
  5. Innovative Research Approaches: His use of advanced methodologies (e.g., neural networks, bioinformatics tools) reflects a commitment to leveraging technology in research, leading to impactful findings.

Areas for Improvement

  1. Project Management Experience: While he has experience managing small teams, expanding his skills in larger project management could enhance his leadership capabilities.
  2. Broader Public Engagement: Increasing visibility through public engagement, such as outreach programs or community workshops, could amplify the impact of his research on society.
  3. Interdisciplinary Collaboration: Encouraging more collaborations outside his primary fields could introduce fresh perspectives and innovative solutions to his work.

 

Education

Nicolas earned his European Doctorate in Biotechnology, where he honed skills in phytopathology, molecular genetics, and bioinformatics. He also holds a PhD in Life Science from Université Pierre et Marie Curie, alongside a Master’s in Management from CEPAC. His academic journey reflects a deep commitment to integrating science and management principles. 🎓📚

Experience

With over 20 years of experience, Nicolas has held prominent research roles in various esteemed institutions. His current position involves leading the bioinformatics platform at CDTS, where he applies his expertise in genomic analysis. He has also contributed to notable projects involving gene identification and genome annotation across multiple organisms. 🧬🔬

Research Focus

Nicolas’s research primarily revolves around bioinformatics applications in public health, including the analysis of infectious and chronic diseases. He employs innovative computational methods to enhance our understanding of disease mechanisms and therapeutic strategies, showcasing his dedication to addressing critical health challenges. 📊🧪

Awards and Honours

Throughout his career, Nicolas has received various recognitions for his contributions to science, reflecting his impact on the field of bioinformatics. His work is not only well-respected but also influential in shaping future research directions. 🏆✨

Publication Highlights

Optimizing therapeutic targets for breast cancer using boolean network models (2024) – Comput Biol Chem

Bioinformatics of infectious and chronic diseases at the Center for Technological Development in Health of Fiocruz (2024) – Journal of Information and Data Management

Unveiling the dynamics behind glioblastoma multiforme single-cell data heterogeneity (2024) – Int. J. Mol. Sci.

Assessing RNA-Seq workflow methodologies using Shannon entropy (2024) – Biology

Structural characterization of heat shock protein 90β and molecular interactions with geldanamycin and ritonavir: A computational study (2024) – Int. J. Mol. Sci.

Conclusion

Nicolas Carels exemplifies the qualities of a strong candidate for the Best Researcher Award. His extensive experience, significant contributions to bioinformatics and public health, and innovative approaches to complex problems position him as a leader in his field. By addressing areas for improvement, he can further enhance his impact and inspire future researchers.